Results 21 to 30 of about 1,327,504 (271)

Exploiting the aggregation propensity of beta-lactamases to design inhibitors that induce enzyme misfolding

open access: yesNature Communications, 2023
There is an arms race between beta-lactam antibiotics development and co-evolving beta-lactamases, which provide resistance by breaking down beta-lactam rings.
Ladan Khodaparast   +13 more
doaj   +1 more source

Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’

open access: yesAntibiotics, 2022
The surge in antimicrobial resistance and the limited availability of new antimicrobial drugs has fueled the interest in optimizing antibiotic dosing. An ideal dosing regimen leads to maximal bacterial cell kill, whilst minimizing the risk of toxicity or
Sofie A. M. Dhaese   +2 more
doaj   +1 more source

Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus

open access: yes, 2022
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most successful human pathogens with the potential to cause significant morbidity and mortality.
Harshad Lade   +5 more
core   +1 more source

Hypersensitivity Reactions to Beta-lactam Antibiotics

open access: yes, 2021
The incidence of hypersensitivity reaction with the use of beta-lactam antibiotics ranges from 5-18%. The prescribing tendency of other antibiotic groups in patients with beta-lactam hypersensitivity causes an increase in the incidence of resistant ...
KALYONCU, ALİ FUAT   +4 more
core   +1 more source

Risk Factors and Characteristics of Adverse Reactions Associated with the Use of Beta-Lactam Antibiotics in Older Patients

open access: yesБезопасность и риск фармакотерапии, 2021
The frequency of adverse drug reactions (ADRs) in older patients is approximately 11.0%, according to scientific literature. Antibiotics are the third largest group (19.5%) of medicinal products in terms of ADR frequency in geriatric patients.
E. A. Sokova   +5 more
doaj   +1 more source

beta-Lactam Allergy in Children

open access: yes, 2021
Objective: beta-lactam antibiotic allergy is the most common drug allergy in children. Most of the patients with suspected reactions to beta-lactam antibiotics can actually tolerate these drugs.
YÜCEL, Esra   +5 more
core   +1 more source

Degradation of beta-lactams in bacterial growth media

open access: yes, 2020
The dataset contains growth curves of E. coli RJA002 in various growth media in the presence of beta-lactam antibiotics. These growth curves were used to determine the degradation rate of these antibiotics in a range of experimental conditions.
Allen, Rosalind J   +2 more
core   +1 more source

Interactions between beta-lactam antibiotics and food, beverages, and dietary supplements - protocol of a systematic review with meta-analyses

open access: yes, 2022
The main objectives of this systematic review are: • to investigate the impact of food, beverages, and dietary supplements on the pharmacokinetic and pharmacodynamic parameters of beta-lactam antibiotics; • to identify the clinically significant drug ...
Paweł Zagrodzki   +2 more
core   +1 more source

Comparison of Effectiveness between Combination of Beta-Lactam with Azyhtromycin or Levofloxacin for Adult Pneumonia Patients

open access: yesPharmacology and Clinical Pharmacy Research, 2018
Treatment for pneumonia has always been a challenge due to the difficulties in diagnosis and the growing incidence of antibiotic resistance. Beta-lactam antibiotics are the first line treatment for pneumonia.
Gina Arifah, Eli Halimah, Rizky Abdulah
doaj   +1 more source

Molecular Glue Degraders of TEM β‐Lactamases by Periplasmic Protease DegP

open access: yesAngewandte Chemie, EarlyView.
Molecular glues are developed that target TEM‐family β‐lactamases to the bacterial protease DegP for degradation. β‐Lactamase inhibitor tazobactam is identified as accelerating TEM β‐lactamase degradation by DegP, which is further enhanced by linkerless incorporation of dipeptides enriched among DegP substrates.
Emilia K. Taylor   +8 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy